Clinical Neurology and Neurosurgery
Volume 107, Issue 5 , Pages 396-403 , August 2005

Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease

  • Yasunori Mito

      Affiliations

    • Department of Neurology, Asahikawa Red Cross Hospital,1-1, Akebono, Asahikawa, Hokkaido 070-8530, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 166 22 8111; fax: +81 166 22 5108.
  • ,
  • Kazuto Yoshida

      Affiliations

    • Department of Neurology, Asahikawa Red Cross Hospital,1-1, Akebono, Asahikawa, Hokkaido 070-8530, Japan
  • ,
  • Ichiro Yabe

      Affiliations

    • Department of Neurology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan
  • ,
  • Kenichi Makino

      Affiliations

    • Department of Neurosurgery, Asahikawa Red Cross Hospital, Asahikawa, Hokkaido, Japan
  • ,
  • Makoto Hirotani

      Affiliations

    • Department of Neurology, Asahikawa Red Cross Hospital,1-1, Akebono, Asahikawa, Hokkaido 070-8530, Japan
  • ,
  • Kunio Tashiro

      Affiliations

    • School of Psychological Science, Health Sciences University of Hokkaido, Sapporo, Hokkaido, Japan
  • ,
  • Seiji Kikuchi

      Affiliations

    • Department of Neurology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan
  • ,
  • Hidenao Sasaki

      Affiliations

    • Department of Neurology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan

Received 13 September 2004 ,Revised 22 November 2004 ,Accepted 10 December 2004.

References 

  1. Friston KJ, Ashburner J, Frith CD, Poline J-B, Heather JD, Frackowiak RSJ. Spatial registration and normalization of images. Hum Brain Mapp. 1995;3:165–189
  2. Ashburner J, Friston KJ. Nonlinear spatial normalization using basis functions. Hum Brain Mapp. 1999;7:254–266
  3. Minoshima S, Berger KL, Lee KS, Mintun MA. An automated method for rotational correction and centering of three-dimensional functional brain images. J Nucl Med. 1992;33:1579–1585
  4. Minoshima S, Koeppe RA, Frey KA, Kuhl DE. Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med. 1994;35:1528–1537
  5. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med. 1995;36:1238–1248
  6. Ishii K, Willoch F, Minoshima S, Drzezga A, Ficaro EP, Cross DJ, et al. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains. J Nucl Med. 2001;42:548–557
  7. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113–1124
  8. Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sorensen P. Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology. 2001;56:730–736
  9. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181–184
  10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939–944
  11. Ichihara T, Ogawa K, Motomura N, Kubo A, Hashimoto S. Compton scatter compensation using the triple-energy window method for single- and dual-isotope SPECT. J Nucl Med. 1993;34:2216–2221
  12. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci. 1978;25:638–643
  13. Kuhl DE, Barrio JR, Huang SC, Selin C, Ackermann RF, Lear JL, et al. Quantifying local cerebral blood flow by N-isopropyl-p-[123I]iodoamphetamine (IMP) tomography. J Nucl Med. 1982;23:196–203
  14. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York: Thieme; 1988;
  15. Worsley KJ, Marrett S, Neelin P, Evans AC. A unified statistical approach for determining significant signals in location and scale space images of cerebral activation. In:  Myers R editors. Quantification of brain function using PET. San Diego: Academic Press; 1996;p. 327–333
  16. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol. 1997;42:85–94
  17. Hanyu H, Asano T, Kogure D, Abe S, Iwamoto T, Takasaki M. Diagnosis of Alzheimer's disease using brain SPECT with three-dimensional stereotactic surface projections. Rinshou Shinkeigaku (Clin Neurol). 2001;41:582–587[in Japanese, abstract in English]
  18. Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O’Brien JT. Regional cerebral blood flow in Parkinson's disease with and without dementia. NeuroImage. 2003;20:1309–1319
  19. Burn DJ, Rowan EN, Minett T, Sanders J, Myint P, Richardson J, et al. Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: a cross-sectional comparative study. Mov Disord. 2003;18:884–889
  20. McKeith IG. Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia. Neurol Clin. 2000;18:865–902
  21. McKeith I, Del Ser T, Spano P, Emre M, Wesnes K, Anand R, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet. 2000;356:2031–2036
  22. Wesnes KA, McKeith IG, Ferrara R, Emre M, Del Ser T, Spano PF, et al. Effects of rivastigmine on cognitive function in dementia with Lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system. Dement Geriatr Cogn Disord. 2002;13:183–192
  23. Bohnen NI, Minoshima S, Giordani B, Frey KA, Kuhl DE. Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia. Neurology. 1999;52:541–546
  24. Vander Borght T, Minoshima S, Giordani B, Foster NL, Frey KA, Berent S, et al. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. J Nucl Med. 1997;38:797–802
  25. Kikuchi A, Takeda A, Kimpara T, Nakagawa M, Kawashima R, Sugiura M, et al. Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease. J Neurol Sci. 2001;193:29–36
  26. Tokuno H, Kimura M, Tanji J. Pallidal inputs to thalamocortical neurons projecting to the supplementary motor area: an anterograde and retrograde double labeling study in the macaque monkey. Exp Brain Res. 1992;90:635–638
  27. Schell GR, Strick PL. The origin of thalamic inputs to the arcuate premotor and supplementary motor areas. J Neurosci. 1984;4:539–560
  28. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 1990;13:281–285
  29. Antonini A, De Notaris R, Benti R, De Gaspari D, Pezzoli G. Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease. Neurol Sci. 2001;22:45–46
  30. Sakai T, Kuzuhara S. Regional cerebral blood flow measured by three-dimensional stereotactic surface projections (3D-SSP) of 123I-IMP SPECT in Parkinson disease patients with cognitive impairment. Rinshou Shinkeigaku (Clin Neurol). 2003;43:183–187[in Japanese, abstract in English]
  31. Sutherland RJ, Whishaw IQ, Kolb B. Contributions of cingulate cortex to two forms of spatial learning and memory. J Neurosci. 1988;8:1863–1872
  32. Minoshima S, Foster NL, Sima AA, Frey KA, Albin RL, Kuhl DE. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol. 2001;50:358–365
  33. Gomez-Tortosa E, Newell K, Irizarry MC, Albert M, Growdon JH, Hyman BT. Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology. 1999;53:1284–1291
  34. Middelkoop HA, van der Flier WM, Burton EJ, Lloyd AJ, Paling S, Barber R, et al. Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI. Neurology. 2001;57:2117–2120
  35. Herholz K, Bauer B, Wienhard K, Kracht L, Mielke R, Lenz MO, et al. In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: comparison with blood flow and glucose metabolism. J Neural Transm. 2000;107:1457–1468
  36. Perry E, Walker M, Grace J. Perry R.Acetylcholine in mind: a neurotransmitter correlate of consciousness?. Trends Neurosci. 1999;22:273–280
  37. Ala TA, Hughes LF, Kyrouac GA, Ghobrial MW, Elble RJ. The mini-mental state exam may help in the differentiation of dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry. 2002;17:503–509

PII: S0303-8467(04)00208-2

doi: 10.1016/j.clineuro.2004.12.005

Clinical Neurology and Neurosurgery
Volume 107, Issue 5 , Pages 396-403 , August 2005